JRJ
DRTX

Jeffrey R. Jay’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Jeffrey R. Jay’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$4.6M Buy
+639,433
New +$4.69M 3.64% 9

Other funds holding DRTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jeffrey R. Jay's DRTX Position: Q2 2013 in Review

Jeffrey R. Jay opened a new position in DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q2 2013: 639,433 shares worth $4.6M. The stake represents 3.64% of the portfolio and ranks #9 among its holdings.

41 funds tracked by Wall St. Rank hold DRTX as of Q2 2013.

  • Jeffrey R. Jay held 639,433 shares of DURATA THERAPEUTICS INC COM STK (DE) worth $4.6M as of Q2 2013.
  • DURATA THERAPEUTICS INC COM STK (DE) was a new Jeffrey R. Jay position in Q2 2013.
  • DURATA THERAPEUTICS INC COM STK (DE) made up 3.64% of Jeffrey R. Jay's portfolio in Q2 2013, its #9 holding.
  • 41 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q2 2013.

Based on Jeffrey R. Jay's 13F filing for Q2 2013, filed 14 Aug 2013.